Clinical Trial Update: A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in children aged 2 to 11 is evaluating the safety and potential efficacy of dexlansoprazole for symptomatic nonerosive gastroesophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexlansoprazole (Dexilant) (Dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 2 | Status: RECRUITING